In a study by Pillai et al. (2025), pain was found to be a common symptom in patients with myositis, with nearly half of the participants reporting moderate to severe pain. The research involved 50 subjects who were assessed at the start, after three months, and again at six months using various pain measurement tools and disease activity scales. The study revealed that pain levels were strongly correlated with disease activity, patient-reported outcomes, and functional measures at the beginning of the study. Moreover, improvements in pain were observed alongside reductions in disease activity over the six-month period.
The study also highlighted that pain assessments using the Short Form 36 survey questions were reliable. This suggests that managing disease activity in myositis could be key to alleviating pain for patients. The findings underscore the importance of pain as a significant factor in myositis, which is closely linked to the overall impact of the disease on patients' lives.